Ph.D. Candidate in Molecular Medicine @ Laboratory of Dr. David Pauza • Characterized immunological defects in Natural Killer cells and Gamma Delta T cells in HIV+ aviremic patients • Awarded $93,834 pre-doctoral NRSA (F31) based on excellent written proposal of current research From September 2012 to Present (3 years 4 months) Research Assistant @ • Organized the collaborative creation of the Southern Network on Adverse Reactions (SONAR) under the supervision of founder Dr. Charles Bennett, resulting in 4 drug safety publications and one book chapter on cancer prevention • Impacted national drug safety by identifying adverse reactions of oncology and hematology treatment options, including tyrosine kinase inhibitors, levamisole, erythropoietin, gadolinium, and lenalidomide • Organized and managed Prostate Cancer Symposium and two-day South Carolina Opioid Safety Initiative conference From September 2011 to August 2012 (1 year) Undergraduate Research Assistant @ • Independently designed, executed, and analyzed in vitro and in vivo experiments using a zebrafish animal model to study the synergistic cross-talk between p53 and B-Raf pathway in melanoma development • Honors Thesis Proposal led to $1,000 Aresty Research Fellowship (maximum award), 2 symposium presentations at Rutgers University, and Departmental Honors upon graduation From August 2009 to August 2011 (2 years 1 month)

Doctor of Philosophy (Ph.D.), Molecular Medicine @ University of Maryland Baltimore From 2012 to 2016 Bachelor of Science (BS), Microbiology, Biochemistry @ Rutgers University-New Brunswick From 2007 to 2011 Alanna Murday is skilled in: Immunotherapy, T cells, Human Immunology, Virology, Molecular Oncology, Cell Culture, Mouse Models, Molecular Biology, Flow Cytometry, Cytotoxicity, PCR, Western Blotting, ELISA, Monoclonal Antibodies, Immunohistochemistry